Pacific Biosciences of California Inc (P09.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
As of 08:10AM CEST. Market open.
| Previous Close | 1.7998 |
| Open | 1.5430 |
| Bid | 1.5432 x 500000 |
| Ask | 1.6148 x 100000 |
| Day's Range | 1.5430 - 1.5430 |
| 52 Week Range | 1.2302 - 13.7400 |
| Volume | |
| Avg. Volume | 3,761 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Soft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 Earnings
Despite strength in Revio and Onso platforms, an increasing number of customers delaying instrument purchases is likely to have dampened PacBio's (PACB) top line in the first quarter.
- Zacks
Investors Heavily Search Pacific Biosciences of California, Inc. (PACB): Here is What You Need to Know
Pacific Biosciences (PACB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- Zacks
Here's Why Pacific Biosciences (PACB) is Poised for a Turnaround After Losing -63.44% in 4 Weeks
Pacific Biosciences (PACB) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
© 2024 Yahoo. All rights reserved.